New Trigger for Alzheimer’s Disease May Have Been Found

Key Points:

• A new study from the University of California, Riverside challenges the traditional view that Alzheimer's disease starts with amyloid beta (a-beta) plaques, suggesting early changes may occur inside nerve cells where a-beta and tau proteins interfere with each other.
• Researchers found that a-beta can bind to microtubules inside neurons, competing with tau for the same binding sites, potentially disrupting the cell’s transport system and initiating disease processes earlier than previously recognized.
• This interaction may explain why treatments targeting amyloid beta plaques have largely failed, indicating that future research should focus on how these proteins interact inside cells rather than solely removing extracellular clumps.
• The study highlights the role of aging-related decline in autophagy, the process that clears unwanted proteins, which may allow intracellular a-beta accumulation and interference with tau function.
• Experts caution that while the findings offer a plausible mechanism linking a-beta and tau, further research is needed to confirm these processes in patients and understand their relationship to Alzheimer's progression before new treatments can be developed.